LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer.
Xi JinLi-Ping GeDa-Qiang LiZhi-Ming ShaoGen-Hong DiXiao-En XuYi-Zhou JiangPublished in: Molecular cancer (2020)
TROJAN promotes ER+ breast cancer proliferation and is a potential target for reversing CDK4/6 inhibitor resistance.